Shorter duration, fully oral treatment regimens for tuberculosis (TB) are now recommended for most adults and children. Updated joint guidelines from the American Thoracic Society, the CDC, European ...
Tuberculosis can recur through relapse or new drug-resistant strains, often triggered by incomplete treatment, a weakened ...
11d
New therapies are transforming treatment for drug-resistant TB – so why aren’t people getting them?
For decades, patients being treated for drug-resistant tuberculosis have had to endure a gruelling regimen of daily injections and a cocktail of drugs with severe side effects.
In the vaccine space, the Gates Medical Research Institute (Gates MRI) is running a Phase III trial of the M72/AS01E vaccine ...
This World Tuberculosis (TB) Day, Médecins Sans Frontières (MSF) urges governments and international donors to bring children to the heart of the global TB response, and commit to investing in the ...
India has launched the world’s first clinical trial to study Ayurveda alongside standard TB treatment. The trial will assess ...
Tuberculosis resurfaced into the national spotlight recently with a sudden resurgence of cases early this year.
The World Health Organization (WHO) called on Tuesday for countries to step up action to end tuberculosis (TB) – one of the ...
A 10% rise in African ancestry lowered odds of moderate TB drug reactions, while a 10% increase in European ancestry raised ...
On the occasion of World Tuberculosis Day, India announced the world’s first clinical study to scientifically evaluate ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results